Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001554258-19-000001
Filing Date
2019-05-03
Accepted
2019-05-03 15:16:08
Documents
1
Effectiveness Date
2019-05-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5857
  Complete submission text file 0001554258-19-000001.txt   6930
Mailing Address 325 SHARON PARK DRIVE SUITE 739 MENLO PARK CA 94025-6805
Business Address 325 SHARON PARK DRIVE SUITE 739 MENLO PARK CA 94025-6805 650-490-4820
TesoRx Pharma, LLC (Filer) CIK: 0001554258 (see all company filings)

EIN.: 273095553 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-338792 | Film No.: 19795816